EPO and stage 5 chronic kidney disease: The major mechanisms that contribute to anemia in CKD are shortened red cell survival2, decreased erythropoietin (EPO) production3, and retained inhibitors or toxic metabolites in end-stage renal disease (ESRD) that inhibit erythropoiesis4–6.